<html>
<head>
  <title>StructureDefinition-cibmtr-additional-peri-transplant-medication-header</title>
  <link rel="stylesheet" href="fhir.css"/>
</head>
<body>
<p class="profile-url-label">
The official URL for this profile is:
</p>
<pre class="profile-url">http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-additional-peri-transplant-medication</pre>
<div class="profile-description">
<p>CIBMTR Additional Drugs Given in the Peri-Transplant Period. Drugs may be given during the peri-transplant period to prevent transplant-related complications, such as liver injuries or to facilitate engraftment.</p>
</div>
<p class="profile-derivation">
This profile builds on <a href="StructureDefinition-cibmtr-medication.html">CIBMTR_Medication</a>.</p>
<p class="profile-publication">
This profile was published on 2025-02-18 15:55:04-0600 as a draft by The Medical College of Wisconsin, Inc. and the National Marrow Donor Program
</p>
</body>
</html>
